MEGAVIT® (Multivitamin syrup)

MEGAVIT® (Multivitamin syrup)

Share this

MEGAVIT® (Multivitamin syrup)

Each 5ml contains

  • Colecalciferol BP (Vitamin D3) BP 400 i.u
  • Vitamin A BP 5000 I.u
  • Thiamine hydrochloride BP (Vitamin B1) 3.0 mg
  • Riboflavin BP (Vitamin B2) 0.856mg
  • Nicotinamide BP (Vitamin B3) 20.0mg
  • Pyridoxine Hydrochloride BP (Vitamin B6) 2.0mg
  • Cyanocobalamin BP (Vitamin B12) 5.0mcg
  • Ascorbic Acid BP (Vitamin C) 10.0mg
  • Dexpanthenol BP (D-Panthenol) 5.0mg

Therapeutic class: A11C- Multivitamins

Indications

Megavit is indicated in vitamins deficiency diseases.

Dosage regimen and directions for use:

As directed by the physician OR

AgeNo. of teaspoonfuls (5ml) a day
< 2 years½
2-12 years1
>12 years2

Contraindications

Vitamin B12 is not given to patient with suspected Vitamin B12 deficiency without first confirming the diagnosis and should not be used to treat megaloblastic anaemia of pregnancy. It should not be used for Uber’s disease or tobacco amblyopia since optic neuropathies may degenerate further. D-Panthenol (Dexpanthenol) is contraindicated in haemophiliacs and in patients with ileus due to mechanical obstruction

Side effects and adverse reactions

Nausea, fatigue and vomiting, gastrointestinal disturbances may occur. Hypercalcuri, ectopic calcification, renal and cardiovascular damage may occur. Hypersensitivity reactions may occur. Rarely allergic hypersensitivity. Arrhythmias secondary to hypokalaemia may occur. Diarrhoea and other gastrointestinal disturbances may occur. There are some rarely allergic reactions associated with the administration of D-Panthenol (Dexpanthenol).

Precautions and warnings

Excessive doses of Vitamin A should be avoided in pregnancy because of potential teratogenic effects. It should be administered with care to infants and should be given with care to patients renal impairments or calculi or heart disease. Administration of doses greater than 10mcg daily of vitamin B12 may produce a haematological response in patients with folate deficiency. It should be given with care to patients with hyperoxaluria. Keep the medicine out of reach of children.

Symptoms and treatment of overdose

Symptoms: Anorexia, loss of weight, irritability, vomiting, other gastrointestinal disturbances, dryness of skin, pruritus, hyperpigmentation, abdominal cramps, diarrhoea, nausea, haematological response in patients with folate deficiency, hylperoxaluria and the formation of renal calcium oxalate calculi.

Treatment: If overdosage is suspected within few hours of ingestion, gastric lavage and/or emesis should be employed. Symptomatic treatment is also of great value.

Share this

Leave a Reply